A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
Clinical trial NCT04959305 · COMPLETED
Trial details
- NCT number
- NCT04959305
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2022-02-28
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.